SCHEMBL4293400

SCHEMBL4293400

CC(=O)OCc1csc(SCC[C@@H]2CN(C(=O)O)CCN2)n1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 2/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA4 P22748 2/20 0.31
CA9 Q16790 2/20 0.31
PTGER3 P43115 1/20 0.30
PTGER2 P43116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8114243 0.88 CXCR4 (0.39) NPC1ALDH1A1TP53NFKB1RAB9A
Hydrochloric Acid SCHEMBL4284863 0.83 GAA (0.40) NPC1ALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL4289928 0.83 GAA (0.34) NPC1ALDH1A1TP53NFKB1RAB9A
SCHEMBL4289003 0.81 HTR1A (0.43) ALDH1A1SMN1; SMN2GAAMAPTPKM
SCHEMBL4284650 0.74 CA1 (0.32) CA1CA2CA4CA9
Hydrochloric Acid SCHEMBL4285632 0.73 GAA (0.43) NPC1ALDH1A1RAB9ASMN1; SMN2GAA
Hydrochloric Acid SCHEMBL4291345 0.73 GPR88 (0.36) NPC1ALDH1A1CA1CA2CA4
Hydrochloric Acid SCHEMBL4287015 0.71 ALDH1A1 (0.51) NPC1ALDH1A1RAB9ASMN1; SMN2MAPT
SCHEMBL4295080 0.69 PDK1 (0.40) NPC1ALDH1A1RAB9ASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL4287846 0.69 SMN1; SMN2 (0.44) NPC1ALDH1A1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227560-A1 Substituted imidazole compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-10 US disclosed
US-20090156612-A1 Substituted imidazole compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-18 US disclosed
WO-2008139941-A1 SUBSTITUTED IMIDAZOLE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156612-A1 Substituted imidazole compound and use thereof REN, ACE, AGT NPC1 1165/4885ALDH1A1 388/4885TP53 2535/4885
US-20090227560-A1 Substituted imidazole compound and use thereof REN, ACE, AGT NPC1 1165/4885ALDH1A1 388/4885TP53 2535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.